San Carlos, CA, United States of America

Steve Kauder

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: An Overview of Inventor Steve Kauder

Introduction

Steve Kauder, an accomplished inventor based in San Carlos, California, has made significant contributions to the field of biotechnology. With a focus on interleukin-2 innovations, his work aims to enhance therapeutic strategies for various human diseases. He holds two patents that exemplify his expertise and creativity in this specialized area.

Latest Patents

Kauder's latest patents include "IL-2 orthologs and methods of use" and "Biased IL2 muteins methods and compositions." The first patent discusses human interleukin-2 (hIL2) orthogonal ligands that interact selectively with a modified hCD122 polypeptide. This innovative approach focuses on activating biological pathways while minimizing unintended interactions with wild type hCD122. The second patent presents hIL2 muteins, along with pharmaceutical formulations and methodologies for their production. These muteins are designed for therapeutic applications to treat human diseases, which highlights Kauder's commitment to advancing medical treatments through biotechnological innovations.

Career Highlights

Steve Kauder currently works at Synthekine, Inc., a company dedicated to developing engineered therapeutic proteins. His scientific contributions, particularly in the realm of immunotherapy, reflect a deep understanding of cytokine biology and its implications in disease treatment. His inventive approaches and novel methodologies distinguish his career in the rapidly evolving field of biomedicine.

Collaborations

Throughout his career, Kauder has collaborated with esteemed colleagues, including Scott Alan McCauley and Martin Oft. These partnerships have facilitated the exchange of ideas and furthered his research, contributing to the advancement of innovative strategies in therapeutic protein design.

Conclusion

Inventor Steve Kauder's work in the development of hIL2 orthologs and muteins has the potential to significantly impact the treatment landscape for human diseases. His innovative patents and collaborations exemplify the important role inventors play in advancing science and technology. As he continues to explore the potential of biotechnological innovations, Kauder remains a notable figure in the pursuit of effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…